Neuromuscular Depolarizing Agents

All categories
DBCAT000512Therapeutic category

Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation. A DrugBank category of 3 drugs. 3 of them are approved.

Part of
Neuromuscular Blocking Agents
Also known as
Agents, Neuromuscular Depolarizing · Blockers, Depolarizing · Depolarizing Agents, Neuromuscular · Depolarizing Blockers · Depolarizing Muscle Relaxants
Drugs

What you can answer from here — as of September 15, 2022

3DrugsEach linked to its full drug card
Listed above
11Drug targetsEvery drug–target pair in the class, with bond type
Sign in
229Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
5Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Neuromuscular Depolarizing Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In